👇👇👇👇👇👇👇

#COI #CDoH #MotivatedBias #DisclosureIsNotEnough

HT @jameslarkin13.bsky.social

bsky.app/profile/jame...

Really wish I could be at #HSRUK25 this year - especially to tune into this discussion...

#COI #CDoH #HealthServicesResearch #PublicHealth #CriticalPublicHealth #Power #WebOfInfluence #DisclosureIsNotEnough

Drug firm payments to professionals widespread - review The practice of drug company payments to healthcare professionals and health organisations in Ireland is widespread, a review has found.

Review recommends that HSE should highlight that it does not support pharmaceutical industry payments to HSE health professionals, accepting that such payments may influence behaviour in a negative way in terms of prescribing medicines

www.rte.ie/news/health/...

#CDoH #COI #DisclosureIsNotEnough

The #COI declarations on some recent #obesity-related papers extend to pages...

Mixing of pharma/biomedical & other (e.g. govt) funding muddies the water in these for me... makes it look like they are equivalent

#DisclosureIsNotEnough... but can we do better in reporting (when we disclose 😉)?

COPE Forum: March 2025 COPE Members! Our March COPE Forum begins with a topic discussion followed by discussions on cases sent in by COPE Members.

COPE Forum Topic Discussion: Declaring funding sources for research

📆 Thursday 20 March 2025, 4pm - 5.30pm (GMT)

🔗 publicationethics.org/events/cope-...

Ping @healthpromint.bsky.social

#CDoH #COI #DisclosureIsNotEnough

Screenshot from the World Obesity Day webpage which lists the logos of 'our partners': Lilly, Vivus, Amgen, Currax, IFA Celtics, Pfizer, Regneron, WAVE, Novo Nordisk. Disclaimer reads "While our supporters have contributed to the funding of the World Obesity Day 2025 campaign, they have no influence on content or execution of the campaign. All activities and materials are developed and created solely by World Obesity Federation in collaboration with our Global Advisory Group and an independent communications agency."

World Obesity Day brought to us by.....

#DisclosureIsNotEnough, (True) #IndependenceNeeded

#COI #CDoH #Obesity #Pharma

www.worldobesityday.org

[And this is not to discount the need to better support people of higher weight, however they wish this support to be provided (if at all)]

Transparency as a means to conquer conflicts of interest is illusory Spectacles, suits, Taylor Swift, and Old Trafford. The register of interests of the UK prime minister, Keir Starmer, has now precipitated a reverse turn.1 The newspapers swooped on the shopping list f...

See also @mgtmccartney.bsky.social's discussion of "willy waving" here 👇

#COI #CDoH #DisclosureIsNotEnough #DarkLogic

www.bmj.com/content/386/...

Home The Transparency Register is a tool to allow European citizens to see what interests are being represented at Union level and on whose behalf, as well as the financial and human resources dedicated to...

Interesting, I didn't know that there was an EU "Transparency Register" transparency-register.europa.eu/index_en

Not sure how complete (or transparent) it is!

Any idea @jameslarkin13.bsky.social?

#COI #CDOH #DisclosureIsNotEnough

Shining a Light on Industry Research Funding

Shining a Light on Industry Research Funding

pmc.ncbi.nlm.nih.gov/articles/PMC...

@mikedaube.bsky.social (2018) - action points still highly relevant!

#COI #DisclosureIsNotEnough #CDoH

Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation New government legislation is necessary to ensure full transparency of industry payments in the UK’s healthcare. A first step should involve challenging the industry-driven discourse that allows compa...

Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation

Piotr Ozieranski, Emily Rickard, Shai Mulinari

ebm.bmj.com/content/earl...

#COI #CDoH #DisclosureIsNotEnough

The Political Sociology of NICE: Investigating Pharmaceutical Cost‐Effectiveness Regulation in the UK The National Institute for Health and Care Excellence (NICE) was established a quarter of a century ago in 1999 to regulate the cost-effectiveness of pharmaceuticals (and other health technologies) f...

The Political Sociology of NICE: Investigating Pharmaceutical Cost-Effectiveness Regulation in the UK

John Abraham, Gowree Balendran

onlinelibrary.wiley.com/doi/10.1111/...

#CDoH #COI #CorporateBias #RevolvingDoors #DisclosureIsNotEnough #MarketisationofNICE

"Collaborations with academia give industry a “social licence to continue and behave in the way that they behave.” David McCoy

“Research journals and academic institutions must rethink their collaborations with the fossil fuel industry.” Anna Gilmore

#CDoH #DisclosureIsNotEnough

Great input so far from Mark Petticrew & @mgtmccartney.bsky.social (knew she'd get the #WillyWaving in 😆... #DisclosureIsNotEnough)

#COI #CDoH #Alcohol #Pharma

#CDoH #CorporatePlaybook #DisclosureIsNotEnough
#WeDontWantYourPens (or your bumbags, or anything else 🐠🎩🥴!)

Dangerous liaisons: how conflicts of interest undermine public health and policy

Dangerous liaisons: how conflicts of interest undermine public health & policy (hybrid event)

Hosted by WHO, BMJ & RCP

Wednesday 20 November, 6.30pm

www.rcp.ac.uk/events-and-e...

#COI #DisclosureIsNotEnough #CDoH